Russia’s mRNA cancer vaccine, launching in 2025, uses AI to personalise treatment, training the immune system to target ...

With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.

BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University ...

Korea boosts drug pricing for domestic raw materials and aims for mRNA vaccine by 2028 Korea announces strategies for enhancing drug production and improving vaccine development by 2028 ...

According to Russian news agency TASS, Russia has developed an mRNA vaccine for cancer. Andrey Kaprin, the General Director ...

The WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continues to closely monitor the genetic and antigenic evolution of SARS-CoV-2 variants, immune responses to SARS-CoV-2 ...

Pennsylvania has so far seen no cases of bird flu in cattle and has not detected a case of the virus in domestic birds in at ...

Despite being a pioneer in developing one of the first and most widely used COVID-19 vaccines, shares of Moderna MRNA have ...

A new Russian-made drug is set to be introduced for treating cancer patients in 2025 Gamaleya center chief Alexander ...

While Russia’s claim that it has developed an mRNA-based cancer vaccine can’t be verified due to a lack of clinical data, ...

A Fremont pharmaceutical company received an investment of approximately $50 million in a private placement from Merck & Co.